Resultats de la cerca - Devreese, Katrien

COVID‐19–related laboratory coagulation findings per Devreese, Katrien M. J.

Obtenir text complet Obtenir text complet Obtenir text complet

The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer per Maelegheer, Karel, Devreese, Katrien M. J.

Obtenir text complet Obtenir text complet Obtenir text complet

Laboratory testing for post ChAdOx1 nCOV‐19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communica... per Vercruysse, Kobe, Devreese, Katrien M.J.

Obtenir text complet Obtenir text complet Obtenir text complet

Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances per Vandevelde, Arne, Devreese, Katrien M. J.

Obtenir text complet Obtenir text complet Obtenir text complet

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results? per De Kesel, Pieter M.M., Devreese, Katrien M.J.

Obtenir text complet Obtenir text complet Obtenir text complet

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome per Devreese, Katrien M.J., Zuily, Stéphane, Meroni, Pier Luigi

Obtenir text complet Obtenir text complet Obtenir text complet

Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples per Linskens, Eleni A., De Kesel, Pieter, Devreese, Katrien M. J.

Obtenir text complet Obtenir text complet Obtenir text complet

Antiphospholipid antibodies in patients with COVID‐19: A relevant observation? per Devreese, Katrien M.J., Linskens, Eleni A., Benoit, Dominique, Peperstraete, Harlinde

Obtenir text complet Obtenir text complet Obtenir text complet

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial per Dhondt, Annemieke, Pauwels, Ruben, Devreese, Katrien, Eloot, Sunny, Glorieux, Griet, Vanholder, Raymond

Obtenir text complet Obtenir text complet Obtenir text complet

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification per Vanoverschelde, Laura, Kelchtermans, Hilde, Musial, Jacek, de Laat, Bas, Devreese, Katrien M. J.

Obtenir text complet Obtenir text complet Obtenir text complet

Optimized alkylated cyclodextrin polysulphates with reduced risks on thromboembolic accidents improve osteoarthritic chondrocyte metabolism per Groeneboer, Sara, Lambrecht, Stijn, Dhollander, Aad, Jacques, Peggy, Cruyssen, Bert Vander, Lories, Rik J., Devreese, Katrien, Chiers, Koen, Elewaut, Dirk, Verbruggen, Gust

Obtenir text complet Obtenir text complet Obtenir text complet

Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome? per Chayoua, Walid, Nicolson, Phillip L. R., Meijers, Joost C. M., Kardeby, Caroline, Garcia‐Quintanilla, Lourdes, Devreese, Katrien M. J., de Laat, Bas, Watson, Stephen P., de Groot, Philip G.

Obtenir text complet Obtenir text complet Obtenir text complet

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions per Vandevelde, Nathalie M., Vermeersch, Pieter, Devreese, Katrien M. J., Vincent, Marie-Françoise, Gulbis, Béatrice, Eyskens, François, Boemer, François, Gothot, André, Van Hoof, Viviane O., Bonroy, Carolien, Stepman, Hedwig, Martens, Geert A., Bossuyt, Xavier, Roosens, Laurence, Smet, Julie, Laeremans, Hilde, Weets, Ilse, Minon, Jean-Marc, Vernelen, Kris, Coucke, Wim

Obtenir text complet Obtenir text complet Obtenir text complet

Development of New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria per Barbhaiya, Medha, Zuily, Stephane, Ahmadzadeh, Yasaman, Amigo, Mary-Carmen, Avcin, Tadej, Bertolaccini, Maria Laura, Branch, D. Ware, de Jesus, Guilherme, Devreese, Katrien M. J., Frances, Camille, Garcia, David, Guillemin, Francis, Levine, Steven R., Levy, Roger A., Lockshin, Michael D., Ortel, Thomas L., Seshan, Surya V., Tektonidou, Maria, Wahl, Denis, Willis, Rohan, Naden, Ray, Costenbader, Karen, Erkan, Doruk

Obtenir text complet Obtenir text complet Obtenir text complet

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress per Ariens, Robert, Becattini, Cecilia, Bender, Markus, Bergmeier, Wolfgang, Castoldi, Elisabetta, Devreese, Katrien, Ellis, Martin, Gailani, David, Ignjatovic, Vera, James, Paula D., Kerrigan, Steven, Lambert, Michele, Lee, Lai Heng, Levi, Marcel, Maugeri, Norma, Meijers, Joost, Melero‐Martin, Juan, Michelson, Alan D., Mingozzi, Federico, Neeves, Keith, Ni, Heyu, Olsson, Anna‐Karin, Prohászka, Zoltán, Ranson, Marie, Riva, Nicoletta, Senis, Yotis, van Ommen, Cornelia H., Vaughan, Douglas E., Weisel, John

Obtenir text complet Obtenir text complet Obtenir text complet

Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study per Paciullo, Francesco, Bury, Loredana, Noris, Patrizia, Falcinelli, Emanuela, Melazzini, Federica, Orsini, Sara, Zaninetti, Carlo, Abdul-Kadir, Rezan, Obeng-Tuudah, Deborah, Heller, Paula G., Glembotsky, Ana C., Fabris, Fabrizio, Rivera, Jose, Lozano, Maria Luisa, Butta, Nora, Favier, Remi, Cid, Ana Rosa, Fouassier, Marc, Podda, Gian Marco, Santoro, Cristina, Grandone, Elvira, Henskens, Yvonne, Nurden, Paquita, Zieger, Barbara, Cuker, Adam, Devreese, Katrien, Tosetto, Alberto, De Candia, Erica, Dupuis, Arnaud, Miyazaki, Koji, Othman, Maha, Gresele, Paolo

Obtenir text complet Obtenir text complet Obtenir text complet